Role of glucagon-like peptide 1 receptor agonists in management of obesity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of glucagon-like peptide 1 receptor agonists in management of obesity

Published:2016-10-01 Issue:19 Volume:73 Page:1493-1507
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Isaacs Diana¹,Prasad-Reddy Lalita²,Srivastava Sneha Baxi³

Affiliation:

1. Chicago State University, Chicago, IL Oak Lawn VA Clinic of Edward Hines Jr. VA Hospital, Oak Lawn, IL

2. Chicago State University, Chicago, IL Rush University Medical Center, Chicago, IL

3. Chicago State University, Chicago, IL ACCESS Community Health Network, Chicago, IL

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/73/19/1493/28335535/ajhp1493.pdf

Reference52 articles.

1. Obesity drugs: review about their effects and safety;Goo Kang;Diabetes Metab J,2012

2. Emerging role of GLP-1 RAs in the treatment of obesity;Neff;Diabetes Metab Syndr Obes,2010

3. Effects of glucagonlike peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials;Monami;Diabetes Obes Metab,2014

4. Prevalence of childhood and adult obesity in the United States, 2011–2012;Ogden;JAMA,2014

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Overweight/Obese and/or T2DM Adolescents: A Meta-analysis Based on Randomized Controlled Trials;Journal of Clinical Research in Pediatric Endocrinology;2024-06-03

2. Clinical Pharmacokinetics of Semaglutide: A Systematic Review;Drug Design, Development and Therapy;2024-06

3. Real‐world glycated haemoglobin changes among type 2 diabetes mellitus patients treated with a maintenance dose of 7 mg or 14 mg of oral semaglutide;Diabetes, Obesity and Metabolism;2024-02-28

4. Comparative analysis of newer classes of antidiabetics and the concept of pharmaceutical care – dealing with therapeutic problems;Pharmacia;2024-02-22

5. Comparative Efficacy of Lifestyle Modifications versus Pharmacotherapy on Weight Loss and Metabolic Health Outcomes: A Comprehensive Review;Journal of Biosciences and Medicines;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3